Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT03366779Phase 4Active Not Recruiting

A Post Marketing Surveillance Study

Role: lead

NCT05467072Unknown

PMCFU of an Annular Closure System

Role: lead

NCT03986580Not ApplicableUnknown

Study of Lumbar Discectomy With Annular Closure

Role: lead

NCT02477176Unknown

Lumbar Discectomy Control Study, Risk Factors for Reherniation

Role: lead

NCT03180749Unknown

Post-Marketing Clinical Follow-Up of a Spine Implant

Role: lead

NCT01283438Phase 4Unknown

A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation

Role: lead

NCT01534065Not ApplicableCompleted

Barricaid EU Post Market Study for Primary Lumbar Disc Herniation

Role: lead

NCT03252691Withdrawn

Incidence of Large Annular Defects in Primary Lumbar Discectomy Patients

Role: lead

All 8 trials loaded